Cardiomyopathy

Related records

Broader conditions (7)

• Cardiovascular disorder
• Disease
• Disease by body system or component
• Heart disorder
• Human disease
• Muscle tissue disorder
• Musculoskeletal system disorder

Narrower conditions (287)

• 46,XY complete gonadal dysgenesis
• 46,XY disorder of sex development due to testicular 17,20-desmolase deficiency
• 46,XY gonadal dysgenesis-motor and sensory neuropathy syndrome
• 46,XY sex reversal 1
• 46,XY sex reversal 10
• 46,XY sex reversal 11
• 46,XY sex reversal 2
• 46,XY sex reversal 3
• 46,XY sex reversal 4
• 46,XY sex reversal 5
• 46,XY sex reversal 6
• 46,XY sex reversal 7
• 46,XY sex reversal 9
• AA amyloidosis
• Acute myocarditis
• AL amyloidosis
• Alcoholic cardiomyopathy
• Arrhythmogenic right ventricular cardiomyopathy
• Arrhythmogenic right ventricular dysplasia 1
• Arrhythmogenic right ventricular dysplasia 10

Trials (553)

• 123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System
• A Bioequivalence Study of Two Formulations of HRS-1893 Tablets in Healthy Participants
• A Comparative Study of Subjects Past Their Final Follow-ON Visit
• A Comparison of Magnetic Resonance Imaging in Persons With Heart Failure to Health, Aged Matched Controls
• A Extension Study to Evaluate Revusiran (ALN-TTRSC) in Patients With Transthyretin (TTR) Cardiac Amyloidosis
• A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease
• A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy
• A Phase 1 Safety Study of the Intravenous Administration of Thymosin Beta in Healthy Volunteers
• A Phase 1/2 Study of High-dose Genetically Targeted Enzyme Replacement Therapy for Advanced Heart Failure
• A Phase 2 Open-label Pilot Study Evaluating MYK-461 in Subjects With Symptomatic Hypertrophic Cardiomyopathy and Left Ventricular Outflow Tract Obstruction
• A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CT-G20 in Subjects With Obstructive Hypertrophic Cardiomyopathy
• A Phase I Trial on the Relative Bioavailability and Food Effect of HRS-1893 Tablets in Healthy Subjects
• A Pilot Study of Empagliflozin in the Treatment of Acromegalic Cardiomyopathy
• A PILOT Study on LSGB vs EMB in the Diagnosis of Cardiac Transthyretin Amyloidosis
• A Preventive, Multidisciplinary Primary Care Intervention Organized Around a Therapeutic Garden: Acceptability to Patients Suffering from Cardio-neurovascular Pathology and to Those Involved in the Action.
• A Psychoeducational Intervention Supporting Patients With an Inherited Cardiac Condition
• A Safety Study Comparing Natrecor (Nesiritide) Versus Dobutamine Therapy for Worsening Congestive Heart Failure
• A Study About the Natural History in Adults With BAG3 Dilated Cardiomyopathy (a Type of Heart Disease) (BAG3 DCM)
• A Study Assessing Arrhythmia Mapping With a Multi-Electrode Mapping Catheter
• A Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation

Approved drugs (4)

• Acoramidis hydrochloride
• Dexrazoxane hydrochloride
• Tafamidis
• Tafamidis meglumine

Drugs in development (21)

• Adenosine Phase 2
• Aficamten Phase 1
• Amiodarone Phase 3
• Atorvastatin Phase 2
• Azathioprine Phase 3
• Carvedilol Phase 2
• Emprumapimod Phase 1
• Enalapril Phase 3
• Eplerenone Phase 3
• Flutemetamol F 18 Phase 1
• Human immunoglobulin G Phase 3
• Interferon beta-1B Phase 2
• Lisinopril anhydrous Phase 2
• Melatonin Phase 3
• Mycophenolate mofetil Phase 2
• Nesiritide Phase 3
• Pravastatin Phase 2
• Prednisolone Phase 2
• Prednisone Phase 3
• Sotagliflozin Early phase 1

Other linked drugs (1)

• Ranolazine